Identifying Over- and Underfunded Diseases by Comparing National Institutes of Health Funding for Skin Disease Research With US Skin Disease Burden According to 2021 Global Burden of Disease Data: Cross-Sectional Analysis
JMIR Dermatology · 2026
DOI: 10.2196/71468 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift JMIR Dermatology, 2026. Verfasst von Aileen Park und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States. Hauptthemen laut MEDLINE: National Institutes of Health (U.S.), Skin Diseases, Global Burden of Disease, Biomedical Research. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Understanding the burden of various skin diseases can help guide funding allocation for skin disease research. A 2015 cross-sectional study found a partial correlation between US skin disease burden according to the 2010 Global Burden of Disease (GBD) study and National Institutes of Health (NIH) funding in 2012-2013.
Objective
This study aims to identify trends, correlations, and disparities in US skin disease burden and NIH research funding allocation using the latest data from the GBD 2021 and NIH funding data from the fiscal years 2021-2022.
Methods
A cross-sectional analysis was conducted to compare the disability-adjusted life years for 15 skin conditions from the GBD 2021 with NIH funding for these conditions in 2021-2022. Data were sourced from the GBD Results tool and the NIH RePORTER database.
Results
NIH funding for skin disease research and US skin disease burden according to the GBD 2021 were partially correlated, with several outliers. Malignant skin melanoma and pruritus were relatively overfunded, while psoriasis and urticaria were relatively underfunded.
Conclusions
Disease burden is just one of the many important factors that must be considered when allocating resources, including funding to encourage research efforts to improve patient outcomes and positively impact public health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
- Kansas City University College of Osteopathic Medicine, Kansas City, MO, United States.
- Memorial Hospital System, Pembroke Pines, FL, United States.
- Paul L. Foster School of Medicine, Texas Tech University, El Paso, TX, United States.
- West Virginia School of Osteopathic Medicine, Lewisburg, WV, United States.
- School of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States.
Zitieren
APA
Park, A., Woolhiser, E., Riva, H., Wan, L., Kadri, H., Lamberty, E., Juels, P., Jaroonwanichkul, S., Reed, M., Hegedus, C., Chen, D., Duffle, D., Kirk, J., Christensen, S., Shelby, E., & Dellavalle, R. (2026). Identifying Over- and Underfunded Diseases by Comparing National Institutes of Health Funding for Skin Disease Research With US Skin Disease Burden According to 2021 Global Burden of Disease Data: Cross-Sectional Analysis. JMIR Dermatology. https://doi.org/10.2196/71468
Vancouver
Park A, Woolhiser E, Riva H, Wan L, Kadri H, Lamberty E, et al. Identifying Over- and Underfunded Diseases by Comparing National Institutes of Health Funding for Skin Disease Research With US Skin Disease Burden According to 2021 Global Burden of Disease Data: Cross-Sectional Analysis. JMIR Dermatology. 2026. doi:10.2196/71468
BibTeX
@article{Park2026,
author = {Park, Aileen and Woolhiser, Emily and Riva, Hannah and Wan, Leo and Kadri, Haaris and Lamberty, Elizabeth and Juels, Parker and Jaroonwanichkul, Sandra and Reed, Madison and Hegedus, Catherine and Chen, Dana and Duffle, Danielle and Kirk, Jessica and Christensen, Sydney and Shelby, Emma and Dellavalle, Robert},
title = {Identifying Over- and Underfunded Diseases by Comparing National Institutes of Health Funding for Skin Disease Research With US Skin Disease Burden According to 2021 Global Burden of Disease Data: Cross-Sectional Analysis},
journal = {JMIR Dermatology},
year = {2026},
doi = {10.2196/71468}
}
EUVIMED